For all the effort and investment drugs companies have put into improving business agility, the gap between vision and reality is glaring. This could be because companies have yet to transform R&D decision-making, says James Man, Kinapse. Read more


Biopharmaceutical solutions organisation, Syneos Health, has acquired an advisory and operational solutions provider to the global life sciences industry, Kinapse, to enhance its end-to-end capabilities. Read more


Pooja Phogat, regulation and compliance expert at Kinapse, advises on the best approaches to balancing the risk of patient re-identification with the need for greater data utility. Read more